Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lutein,Curcumin,Zeaxanthin
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bausch + Lomb Launches Blink NutriTears Supplement For Dry Eyes In US
Details : Blink NutriTears is a clinically proven nutritional supplement developed to help relieve dry eye symptoms. It contains a proprietary blend of lutein, zeaxanthin, curcumin, & vitamin D.
Product Name : Blink NutriTears
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 06, 2024
Lead Product(s) : Lutein,Curcumin,Zeaxanthin
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lutein,Astaxanthin
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Sponsor : LY Research Corporation
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : The agreement aims to market a patented product for Eye Health due to Myopia and Presbyopia. This Patent is a liposome and sustained release polymeric micelles preparation that improves the solubility of lutein.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Undisclosed
March 30, 2023
Lead Product(s) : Lutein,Astaxanthin
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Sponsor : LY Research Corporation
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Lead Product(s) : Lutein
Therapeutic Area : Ophthalmology
Study Phase : Phase I/ Phase II
Sponsor : Heidelberg Engineering GmbH | MacuHealth | Industrial Orgánica S.A. de C.V.
Deal Size : Inapplicable
Deal Type : Inapplicable
Macular Pigment and Visual Performance in Glaucoma Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 22, 2019
Lead Product(s) : Lutein
Therapeutic Area : Ophthalmology
Highest Development Status : Phase I/ Phase II
Sponsor : Heidelberg Engineering GmbH | MacuHealth | Industrial Orgánica S.A. de C.V.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lutein
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : European Regional Development Fund | Ministry of Education, Science and Sport, Republic of Slovenia | Dermatologija Bartenjev Rogl | Slovenian Research Agency | Valens Int. d.o.o., Slovenija
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effect of 12-Week Dietary Intake of Lutein on Minimal Erythema Dose and Other Skin Parameters
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 22, 2019
Lead Product(s) : Lutein
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : European Regional Development Fund | Ministry of Education, Science and Sport, Republic of Slovenia | Dermatologija Bartenjev Rogl | Slovenian Research Agency | Valens Int. d.o.o., Slovenija
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lutein
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Benefits of FloraGLOâ„¢ Lutein on Skin Health
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 10, 2018
Lead Product(s) : Lutein
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lutein
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Royal DSM
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Lutein on Visual Function
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
April 14, 2017
Lead Product(s) : Lutein
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Royal DSM
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lutein
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Sprim Advanced Life Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Intervention Trial in Early Age-related Macular Degeneration
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 27, 2012
Lead Product(s) : Lutein
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Sprim Advanced Life Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lutein
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Cognis Deutschland GmbH & Co. KG
Deal Size : Inapplicable
Deal Type : Inapplicable
The Influence of Lutein Supplements on Age-related Macular Degeneration
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 06, 2010
Lead Product(s) : Lutein
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Cognis Deutschland GmbH & Co. KG
Deal Size : Inapplicable
Deal Type : Inapplicable